The role of the senescent microenvironment on cancer initiating cells in the colon.

衰老微环境对结肠癌起始细胞的作用。

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT Advanced age is the single most significant risk factor for cancer. Although there are many plausible age-related mechanisms that mediate the increased risk for cancer in the elderly, functional evidence is lacking for the majority of these mechanisms. This proposal will focus on the role of the aged microenvironment, particularly senescence, in promoting the formation of colorectal cancer (CRC), which is a common age-related cancer in the U.S. It is well established that the majority of CRCs arise through the serial accumulation of mutations and epigenetic alterations in oncogenes and tumor suppressor genes in colon epithelial stem cells. However, our group and others have found cells with cancer-causing DNA alterations (e.g. oncogenic KRAS and TP53) in the histologically normal colon mucosa of people, which suggests that the DNA alterations alone are not sufficient to drive the complete CRC formation process. Our group has recently shown that a senescent normal colon tissue microenvironment can promote the neoplastic behavior of colon epithelial cells ex vivo. We found increased senescent fibroblasts in the colons of the elderly and of people at high risk for CRC. We found that certain senescence associated secretory phenotype (SASP) factors produced by senescent fibroblasts can induce cancer hallmark behaviors through the activation of oncogenic signaling pathways. Based on our preliminary data we hypothesize that senescent fibroblasts in older people and the accompanying specific Senescence Associated Secretory Phenotype (SASP) secreted proteins promote the tumorigenesis of colon epithelial cells that have acquired age-related oncogenic mutations, which we have defined as cancer-initiating cells. To provide direct functional evidence to test this hypothesis, we propose the following Specific Aims: AIM 1A. To determine whether senescent fibroblasts can promote the survival and/or transformation of colon cancer initiating cells in ex vivo and in vivo organoid model systems. AIM 1B. To determine the necessary and sufficient role of specific cancer-associated SASP factors produced by the senescent fibroblasts in cancer formation. AIM 2. To determine whether a senescent tissue microenvironment is necessary for the survival and clonal expansion of mutant APC and mutant KRAS cancer-initiating cells using a well characterized CRC mouse model, the inducible Villin-Cre;Apcflx/flx; KrasLSL-G12D (AK) mice, with two approaches: AIM 2A: a pharmacological approach using the senomorphic drug rapamycin and the senolytic drug treatment DNQ (dasatinib and quercetin) AIM 2B: a genetic approach using the p16-3MR transgenic model, which allows the inducible ablation of senescent cells.
项目总结/摘要 高龄是癌症最重要的风险因素。虽然有很多 似乎与年龄有关的机制介导了老年人癌症风险的增加, 大多数这些机制缺乏功能证据。该提案将重点关注 老年微环境的作用,特别是衰老,在促进形成 结直肠癌(CRC),这是一种常见的年龄相关的癌症在美国。 大多数CRCs是通过突变和表观遗传的连续积累而产生的, 结肠上皮干细胞中癌基因和肿瘤抑制基因的改变。然而,在这方面, 我们小组和其他人已经发现了具有致癌DNA改变的细胞(例如致癌KRAS 和TP 53)在组织学正常的结肠粘膜的人,这表明, 单独的改变不足以驱动完整的CRC形成过程。 我们的研究小组最近表明,衰老的正常结肠组织微环境可以 促进离体结肠上皮细胞的肿瘤行为。我们发现衰老的增加 成纤维细胞在老年人和CRC高危人群的结肠。我们发现某些 由衰老成纤维细胞产生的衰老相关分泌表型(SASP)因子 可以通过致癌信号通路的激活诱导癌症标志行为。 根据我们的初步数据,我们假设老年人和老年人的衰老成纤维细胞, 伴随特定衰老相关分泌表型(SASP)分泌蛋白 促进结肠上皮细胞的肿瘤发生, 突变,我们将其定义为癌症起始细胞。提供直接的功能性证据 为了验证这一假设,我们提出了以下具体目标: AIM 1A.确定衰老的成纤维细胞是否可以促进存活和/或 在离体和体内类器官模型系统中转化结肠癌起始细胞。 AIM 1B.确定特定癌症相关SASP的必要和充分作用 在癌症形成中由衰老的成纤维细胞产生的因子。 AIM 2.为了确定衰老的组织微环境是否是生存所必需的, 和突变型APC和突变型KRAS癌症起始细胞的克隆扩增 表征的CRC小鼠模型,诱导型Villin-Cre;Apcflx/flx; KrasLSL-G12 D(AK)小鼠,具有两个 方法:AIM 2A:使用senomorphic药物雷帕霉素和 衰老清除药物治疗DNQ(达沙替尼和槲皮素)AIM 2B:一种使用 p16- 3 MR转基因模型,允许衰老细胞的诱导性消融。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William Mallory Grady其他文献

CPG island methylator phenotype and patients with multiple colorectal cancers
  • DOI:
    10.1016/s0016-5085(00)82254-4
  • 发表时间:
    2000-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    William Mallory Grady;Sanford Markowitz;Joseph Willis
  • 通讯作者:
    Joseph Willis

William Mallory Grady的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William Mallory Grady', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10519073
  • 财政年份:
    2022
  • 资助金额:
    $ 45.2万
  • 项目类别:
Administrative Core-Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus
用于优化结肠癌和食道癌风险预测和早期检测的管理核心生物标志物
  • 批准号:
    10677826
  • 财政年份:
    2022
  • 资助金额:
    $ 45.2万
  • 项目类别:
Comprehensive atlas of advanced adenomas and their surrounding primed colon: A multi-omics evaluation and clinical impact assessment
晚期腺瘤及其周围的结肠的综合图谱:多组学评估和临床影响评估
  • 批准号:
    10707100
  • 财政年份:
    2022
  • 资助金额:
    $ 45.2万
  • 项目类别:
Biomarker Development Laboratory
生物标志物开发实验室
  • 批准号:
    10677827
  • 财政年份:
    2022
  • 资助金额:
    $ 45.2万
  • 项目类别:
Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus
用于优化结肠癌和食道癌风险预测和早期检测的生物标志物
  • 批准号:
    10677825
  • 财政年份:
    2022
  • 资助金额:
    $ 45.2万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10707097
  • 财政年份:
    2022
  • 资助金额:
    $ 45.2万
  • 项目类别:
Comprehensive atlas of advanced adenomas and their surrounding primed colon: A multi-omics evaluation and clinical impact assessment
晚期腺瘤及其周围的结肠的综合图谱:多组学评估和临床影响评估
  • 批准号:
    10920978
  • 财政年份:
    2022
  • 资助金额:
    $ 45.2万
  • 项目类别:
Comprehensive atlas of advanced adenomas and their surrounding primed colon: A multi-omics evaluation and clinical impact assessment
晚期腺瘤及其周围的结肠的综合图谱:多组学评估和临床影响评估
  • 批准号:
    10519074
  • 财政年份:
    2022
  • 资助金额:
    $ 45.2万
  • 项目类别:
Liver Cancer Disparities in Alaska Native and American Indian People
阿拉斯加原住民和美洲印第安人的肝癌差异
  • 批准号:
    10286757
  • 财政年份:
    2021
  • 资助金额:
    $ 45.2万
  • 项目类别:
The intestinal microbiome contribution to colon cancer and senescence
肠道微生物组对结肠癌和衰老的贡献
  • 批准号:
    10831334
  • 财政年份:
    2021
  • 资助金额:
    $ 45.2万
  • 项目类别:

相似海外基金

Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
  • 批准号:
    24K21101
  • 财政年份:
    2024
  • 资助金额:
    $ 45.2万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
  • 批准号:
    24K11201
  • 财政年份:
    2024
  • 资助金额:
    $ 45.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
  • 批准号:
    24K11281
  • 财政年份:
    2024
  • 资助金额:
    $ 45.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
  • 批准号:
    2338890
  • 财政年份:
    2024
  • 资助金额:
    $ 45.2万
  • 项目类别:
    Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
  • 批准号:
    2334777
  • 财政年份:
    2024
  • 资助金额:
    $ 45.2万
  • 项目类别:
    Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
  • 批准号:
    2334775
  • 财政年份:
    2024
  • 资助金额:
    $ 45.2万
  • 项目类别:
    Continuing Grant
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
  • 批准号:
    EP/Z001145/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.2万
  • 项目类别:
    Fellowship
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
  • 批准号:
    2334776
  • 财政年份:
    2024
  • 资助金额:
    $ 45.2万
  • 项目类别:
    Continuing Grant
Cryo laser-ablation system (157+193nm) with 'triple-quad' plasma mass spectrometer, Cryo-LA-ICPMS/MS
带有“三重四极杆”等离子体质谱仪、Cryo-LA-ICPMS/MS 的冷冻激光烧蚀系统 (157 193nm)
  • 批准号:
    515081333
  • 财政年份:
    2023
  • 资助金额:
    $ 45.2万
  • 项目类别:
    Major Research Instrumentation
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
  • 批准号:
    2320040
  • 财政年份:
    2023
  • 资助金额:
    $ 45.2万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了